Oxford University Press

NAR Cancer Template

Write in a clean editor, then format for NAR Cancer in one click — DocuGuru applies the official Oxford University Press template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the NAR Cancer format

NAR Cancer is a peer-reviewed journal published by Oxford University Press, covering DNA Repair Mechanisms, RNA modifications and cancer, Cancer Genomics and Diagnostics.

PublisherOxford University Press
Reference styleAuthor–year (OUP)
Author–year — (Smith, 2023) in the text
Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', NAR Cancer, 12(3), pp. 45–58.

Formats any DOI in the closest standard style — NAR Cancer has no published style definition, so this is an approximation. No sign-up.

Publishes research inDNA Repair Mechanisms RNA modifications and cancer Cancer Genomics and Diagnostics RNA Research and Splicing PARP inhibition in cancer therapy
ISSN2632-8674
Citation impact (2-yr)5.32
h-index34
i10-index159
Total citations5,092
Article processing charge$2,225
Open accessYes
Top institutions publishing hereCentre National de la Recherche Scientifique
Journal websiteacademic.oup.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in NAR Cancer per year

1
2011
1
2019
38
2020
57
2021
45
2022
63
2023
50
2024
61
2025

Citation impact of NAR Cancer by publication year

0
2011
1
2019
1.6K
2020
1.4K
2021
725
2022
759
2023
489
2024
129
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in NAR Cancer

Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times

Christian Bailly, Xavier Thuru, Bruno Quesnel · 17 Feb 2020

Monoclonal antibodies targeting programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) immune checkpoints have improved the treatments of cancers. However, not all patients equally benefit from immunotherapy. The use of cytotoxic drugs is practically inevitable to treat advanced cancers and metastases. The repertoire of cytotoxics includes 80 products that principally target nucleic acids or…

Replication protein A: a multifunctional protein with roles in DNA replication, repair and beyond

Rositsa Dueva, George Iliakis · 1 Sep 2020

Single-stranded DNA (ssDNA) forms continuously during DNA replication and is an important intermediate during recombination-mediated repair of damaged DNA. Replication protein A (RPA) is the major eukaryotic ssDNA-binding protein. As such, RPA protects the transiently formed ssDNA from nucleolytic degradation and serves as a physical platform for the recruitment of DNA damage response factors. Prominent…

Ribosomal RNA 2′O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer

Virginie Marcel, Janice Kielbassa, Virginie Marchand et al. · 1 Dec 2020

Recent epitranscriptomics studies unravelled that ribosomal RNA (rRNA) 2'O-methylation is an additional layer of gene expression regulation highlighting the ribosome as a novel actor of translation control. However, this major finding lies on evidences coming mainly, if not exclusively, from cellular models. Using the innovative next-generation RiboMeth-seq technology, we established the first rRNA 2'O-methylation landscape…

Regulation and pharmacological targeting of RAD51 in cancer

McKenzie K. Grundy, Ronald J. Buckanovich, Kara A. Bernstein · 1 Sep 2020

Regulation of homologous recombination (HR) is central for cancer prevention. However, too little HR can increase cancer incidence, whereas too much HR can drive cancer resistance to therapy. Importantly, therapeutics targeting HR deficiency have demonstrated a profound efficacy in the clinic improving patient outcomes, particularly for breast and ovarian cancer. RAD51 is central to DNA…

Quantification of radiation-induced DNA double strand break repair foci to evaluate and predict biological responses to ionizing radiation

Sébastien Penninckx, Eloise Pariset, Egle Cekanaviciute et al. · 4 Oct 2021

Abstract Radiation-induced foci (RIF) are nuclear puncta visualized by immunostaining of proteins that regulate DNA double-strand break (DSB) repair after exposure to ionizing radiation. RIF are a standard metric for measuring DSB formation and repair in clinical, environmental and space radiobiology. The time course and dose dependence of their formation has great potential to predict…

NAR Cancer template — frequently asked questions

How do I write a paper in the NAR Cancer format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the NAR Cancer template. When you export, DocuGuru compiles the paper into the official Oxford University Press format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does NAR Cancer use?
NAR Cancer uses Author–year (OUP) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', NAR Cancer, 12(3), pp. 45–58.
Do I need to know LaTeX to submit to NAR Cancer?
No. DocuGuru generates the oup-authoring-template LaTeX class and compiles the PDF for you in the background, so you get a Oxford University Press-ready NAR Cancer document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the NAR Cancer template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the NAR Cancer format with correct headings, figures, tables, and author–year citations.
Who publishes NAR Cancer?
NAR Cancer is a multidisciplinary journal published by Oxford University Press. DocuGuru's NAR Cancer template matches Oxford University Press's official submission format.
Can I export a submission-ready NAR Cancer PDF?
Yes — DocuGuru produces a PDF built with the official NAR Cancer template (the oup-authoring-template class) that is ready to submit to Oxford University Press, together with the matching LaTeX source files.
How much does the NAR Cancer template cost?
You can start writing in the NAR Cancer template for free. Exporting the final submission-ready NAR Cancer PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the NAR Cancer template